Literature DB >> 7692105

Similar levels of urological symptoms have similar impact on Scottish and American men--although Scots report less symptoms.

H A Guess1, C G Chute, W M Garraway, C J Girman, L A Panser, R J Lee, S J Jacobsen, G B McKelvie, J E Oesterling, M M Lieber.   

Abstract

Urinary symptoms and the extent to which they interfere with living activities were compared in 2 community-based investigations that enrolled men 40 to 79 years old who were randomly sampled from Olmsted County, Minnesota (2,119) and the Forth Valley of Scotland (1,385). Both investigations included symptom questions with wording that is nearly identical to that of the American Urological Association (AUA) symptom index. Following AUA scoring conventions we grouped scores into mild (AUA score 0 to 7), moderate (score 8 to 19) and severe (score 20+) categories. Minnesota men had symptoms that were more frequent, more bothersome and caused greater interference with living activities than did Scottish men of comparable age (p < 0.0002). However, within each symptom score category, the extent to which symptoms interfered with living activities was essentially the same in both populations. Although there appear to be important differences in urinary symptom prevalence between Scotland and Minnesota, the AUA symptom index provides a consistent measure of the extent to which urinary symptoms interfere with living activities in both populations. These findings support use of the AUA symptom index in the diagnostic evaluation of men with benign prostatic hyperplasia.

Entities:  

Mesh:

Year:  1993        PMID: 7692105     DOI: 10.1016/s0022-5347(17)35871-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Health-related quality of life in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Fei-Li Zhao; Ming Yue; Hua Yang; Tian Wang; Jiu-Hong Wu; Shu-Chuen Li
Journal:  Qual Life Res       Date:  2010-06-24       Impact factor: 4.147

2.  Correlates of urinary symptom scores in men.

Authors:  B E Klein; R Klein; K E Lee; R C Bruskewitz
Journal:  Am J Public Health       Date:  1999-11       Impact factor: 9.308

3.  Endoscopic ablation for benign enlargement of the prostate.

Authors:  Sean P Elliott
Journal:  BMJ       Date:  2008-06-30

Review 4.  Quality-of-life assessment in patients with benign prostatic hyperplasia: effects of various interventions.

Authors:  J E Batista-Miranda; M D Diez; P A Bertrán; H Villavicencio
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 5.  Tamsulosin: an update of its role in the management of lower urinary tract symptoms.

Authors:  Katherine A Lyseng-Williamson; Blair Jarvis; Antona J Wagstaff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables.

Authors:  G Haidinger; S Madersbacher; T Waldhoer; G Lunglmayr; C Vutuc
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

7.  Reducing the risk of benign prostatic hyperplasia progression.

Authors:  Claus G Roehrborn
Journal:  Rev Urol       Date:  2002

8.  Validity of the "bother score" in the evaluation and treatment of symptomatic benign prostatic hyperplasia.

Authors:  Michael P O'leary
Journal:  Rev Urol       Date:  2005

Review 9.  Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms.

Authors:  Christopher J Dunn; Anna Matheson; Diana M Faulds
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  The impact of lower urinary tract symptoms on general health status and on the use of prostatectomy.

Authors:  D J Hunter; C M McKee; N A Black; C F Sanderson
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.